Number Of Filed Xarelto Lawsuits Continues To Increase

March 02, 2017 – – Drug-Lawsuits.org is an organization that provides consumer information on various medical related lawsuits. The company has recently reported that the number of Xarelto lawsuits has continued to climb, surpassing over 13,000 pending cases in courts around the nation.

“Just over two years ago Xarelto lawsuits were consolidated into one court in Louisiana,” says a spokesperson for the website. “Since that time, there have been numerous additional suits filed, all against this same medication manufacturer.”

The lawsuits target Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. The suits claim that the company, along with Bayer AG, failed to provide consumers with adequate warnings about the potentially dangerous side effects of taking the medication. The lawsuits allege that the anticoagulant has the potential to cause bleeding, which can be difficult to stop.

“In one such case,” says the spokesperson for Drug-Lawsuits.org, “a woman in Illinois claims that after taking Xarelto, she suffered a stroke, uncontrolled hemorrhages and internal bleeding. She points out that she never received a warning about such potential side effects.”

Originally approved for use in 2011, Xarelto was reportedly supposed to help reduce the risk of blood clots as well as pulmonary embolism and deep vein thrombosis. It was originally provided to patients after having hip and knee replacement surgery and later approved for those who were at high risks of stroke and blood clots.

Patients taking Warfarin were encouraged to switch to Xarelto because it was a more convenient drug of choice that claimed to treat the same medical issues. Experts state that the major difference in the drugs is the ability to treat side effects. Patients on Warfarin can reverse uncontrolled bleeding by taking vitamin K injections. To date, there has been no way to stop the bleeding in patients who have taken Xarelto.

The first few trials for Xarelto lawsuits were set to begin in February 2017, although those cases have been pushed back to the middle of March 2017. As the trials for those first few cases loom, more and more patients have filed lawsuits against the medication manufacturers and experts believe that more are yet to come.

###

Contact Drug-Lawsuits.org:

info@drug-lawsuits.org

ReleaseID: 60015228